BOULDER, Colo., Feb. 7, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the LEERINK Partners 7th Annual Global Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: |
LEERINK Partners Annual Global Healthcare Conference |
Presenter: |
Ron Squarer, Chief Executive Officer, Array BioPharma |
Date: |
Wednesday, February 14, 2018 |
Time: |
1:30 p.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). For more information on Array, please go to www.arraybiopharma.com.
CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
[email protected]
SOURCE Array BioPharma Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article